title: The anticancer effect of histone deacetylase inhibitors and combination with the cytotoxic agents in lung cancer cells: biological analyses for future clinical application.
authors.affiliation: Department of Pulmonary Medicine/Infection and Oncology, Nippon Medical School, Tokyo, Japan.
authors.forename: Rintaro
authors.initials: R
authors.lastname: Noro
authors.forename: Akihiko
authors.initials: A
authors.lastname: Miyanaga
authors.forename: Tsuneo
authors.initials: T
authors.lastname: Shimokawa
authors.forename: Hidehiko
authors.initials: H
authors.lastname: Kuribayashi
authors.forename: Hideaki
authors.initials: H
authors.lastname: Mizutani
authors.forename: Yuji
authors.initials: Y
authors.lastname: Minegishi
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Okano
authors.forename: Masahiro
authors.initials: M
authors.lastname: Seike
authors.forename: Chie
authors.initials: C
authors.lastname: Soeno
authors.forename: Kiyoko
authors.initials: K
authors.lastname: Kataoka
authors.forename: Kuniko
authors.initials: K
authors.lastname: Matsuda
authors.forename: Akinobu
authors.initials: A
authors.lastname: Yoshimura
authors.forename: Akihiko
authors.initials: A
authors.lastname: Gemma
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004354:Drug Screening Assays, Antitumor; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D006877:Hydroxamic Acids / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy*; D014407:Tumor Cells, Cultured; D000077337:Vorinostat
chemical_list: D000970:Antineoplastic Agents; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; C012589:trichostatin A; D000077337:Vorinostat